Dr. Julie Joann Miller, MD, PhD

Dr. Miller practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Miller's NPI, 1073804431, was assigned on April 20, 2011. Dr. Miller graduated from Stanford University School of Medicine in 2011. Dr. Miller holds Massachusetts license 258956.

Dr. Miller's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Miller's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Miller is also affiliated with Massachusetts Eye and Ear. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Miller to 2 more medical groups and 1 community health center, each named with a free account. Dr. Miller's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Miller is licensed in Massachusetts.

CMS data shows 85 Medicare services from Dr. Miller across 2 procedure codes in 2024, for 54 Medicare patients. Medicare paid $8,797 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Dr. Miller in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 69, with 55% women.

In 2024, Dr. Miller wrote 36 Medicare Part D claims for 14 patients. 64% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $8,057 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miller as offering telehealth.

Dmand AI links 31 papers to Dr. Miller, published from 2020 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Glioma, Isocitrate Dehydrogenase and Brain Neoplasms. Dr. Miller has published most often in Neuro Oncol. Dr. Miller's most frequent co-authors are Daniel P. Cahill, MD, PhD, Bryan D. Choi, MD, PhD and Patrick Yung Wen, MD.

CMS Open Payments shows 5 general payments to Dr. Miller from 2 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 94% of the total. Servier Pharmaceuticals LLC paid the most, $6,220.

Dr. Miller graduated from Stanford University School of Medicine in 2011.